LIPIDEM

This brand name is authorized in Brazil, Estonia, Hong Kong, Poland, United Kingdom

Active ingredients

The drug LIPIDEM contains a combination of these active pharmaceutical ingredients (APIs):

1 Triglycerides, medium chain UNII C9H2L21V7U - MEDIUM-CHAIN TRIGLYCERIDES

Read about Triglycerides, medium chain

2 Omega-3-acid ethyl esters UNII 71M78END5S - OMEGA-3 FATTY ACIDS

Read about Omega-3-acid ethyl esters

3 Soybean oil, refined UNII 241ATL177A - SOYBEAN OIL

Read about Soybean oil, refined

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 520906401158415, 520920080013207, 520920080013307
Country: EE	Ravimiamet	Identifier(s): 1639638, 1639649, 1639650, 1639661, 1639672, 1639683, 1639694, 1639706
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 114691, 114701, 114705, 239859, 239861, 239863
Country: HK	Department of Health Drug Office	Identifier(s): 58945
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100333299